Introduction Generalized Myasthenia Gravis (gMG) is a chronic autoimmune neuromuscular disorder driven by pathogenic Immunoglobulin G (IgG) autoantibodies, most commonly targeting the acetylcholine receptor (AChR), muscle-specific tyrosine kinase (MuSK), or low-density lipoprotein receptor-related protein 4 (LRP4). These antibodies impair neuromusc
4 Reached
Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes
Young Girl Presented with Irritability and Abnormal Behavior
2254 Reached10 Comments4 Likes
Spinal Anesthesia in Elderly Patient
4200 Reached10 Comments7 Likes
Unconscious Male in ED following Loss of Motorcycle Control
828 Reached2 Comments2 Likes
Neurotrophic Deep Corneal Ulcer in Old Male
1139 Reached5 Comments4 Likes